S6 Ep1: Seeing Eye to Eye: FDA's Dr Sarah Yim Discusses Efforts to Increase Confidence in Ophthalmology Biosimilars

Not So Different: a Podcast from The Center for Biosimilars

Audioboom and Not So Different: a Podcast from The Center for Biosimilars에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Audioboom and Not So Different: a Podcast from The Center for Biosimilars 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

1y ago 13:50

MP3•에피소드 홈

To check out part 1 of this interview series (written Q&A with Samsung Bioepis’ Kyung-Ah Kim), click here.
Coming soon, part 3 will be a video interview about the initial market response to ophthalmology biosimilars and how industry leaders can work together to increase uptake.

To learn more about the approval of Cimerli, click here.
To learn more about ophthalmology biosimilars, click here.
To learn more about interchangeability, click here.
To learn more about clinical efficacy testing, click here.
To learn more about our LinkedIn Live event on ophthalmology biosimilars, you can read more here or watch the full discussion here.

To check out the FDA’s overview page on biosimilars, click here.
To check out the FDA’s patient-focused biosimilar education materials (English and Spanish versions), click here.
To check out the FDA’s biosimilar education materials for health care professionals, click here.
For more information on the FDA's biosimilar curriculum, click here.
For more information on the FDA's free CE courses on biosimilars, click here and use the filter function to select biosimilars.

139 에피소드

#Fitness #Audioboom #Not So Different: a Podcast from The Center for Biosimilars #United States